NewsRoom Articles - Page 52 of 207

FridayOct 06, 2023 11:52 am

First Time Ever: Researchers Eliminate Brain Cancer Using Quantum Therapy

University of Nottingham scientists have developed a new quantum therapeutic approach to treating cancer that could treat one of the most aggressive types of brain cancer, glioblastoma. The researchers created a new spray treatment capable of treating glioblastoma through quantum signaling, making their treatment the first-ever, quantum-therapy-based treatment. This unique treatment works by changing neural cells at a quantum level via bio-nanoantennas, nano-particles of gold coated in redox-active molecules. According to the researchers, the novel treatment involves spraying glioblastoma tumor sites with bio-nanoantennae followed by the application of an electric field. University of Nottingham research fellow and study coauthor Frannkie…

ThursdayOct 05, 2023 12:38 pm

Researchers Find Psoriasis Increases Risk of Heart Disease

Researchers have observed coronary microvascular dysfunction in a good number of patients with psoriasis. This is despite the fact that most of them hadn’t presented with any symptoms of cardiovascular illness. For their study, the researchers recruited 503 individuals who had been diagnosed with psoriasis but had not been diagnosed with cardiovascular disease. Prior research has demonstrated that individuals with severe psoriasis have heightened cardiovascular mortality and morbidity. Despite this, there’s been limited studies on the mechanisms underlying the heightened risk. The researchers were focused on learning more about the link between psoriasis and heart disease, centering on coronary blood…

WednesdayOct 04, 2023 3:32 pm

New Prediction Model Could Slash Unnecessary Pancreatic Cancer Biopsies

Researchers have developed a new prediction model capable of “reliably detecting” pancreatic cancer in its early stages. The prediction model leverages regularly measured biomarkers in the blood to sharpen diagnostic processes for pancreatic cancer and reduce the need for unnecessary biopsy procedures by 6%. Pancreatic cancer is difficult to diagnose in its early stages because the pancreas is generally hidden by other organs and is located deep in the abdomen. Furthermore, pancreatic cancer often displays no physical symptoms until the cancer has metastasized to other organs, which makes the condition easy to miss during physical exams or through analyzing symptoms.…

WednesdayOct 04, 2023 9:45 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Secures $1.33 Million from Registered Direct Offering to Boost Commercial Development

Scinai Immunotherapeutics recently announced the closing of a registered direct offering, raising $1.33 million in gross proceeds The company intends to use the net proceed from the offering for, among others, research and development On its R&D agenda is the development and commercialization of novel innovative NanoAbs targeting a wide range of diseases with known and validated antibody drug targets This strategic approach is expected to shorten development timelines, reduce the budgetary requirements, and increase probability of drug approval The company has also expanded into the CDMO business to plug an existing gap in the market, raising recurring revenue as…

TuesdayOct 03, 2023 1:51 pm

TikTok Hit as Indonesia Announces e-Commerce Transaction Ban on Social Media

Indonesian authorities dealt a major blow to TikTok’s expansion plans after they announced a national ban on virtual transactions on social media platforms. The social media platform TikTok has been working to accelerate e-commerce transactions in Indonesia, its largest market in Southeast Asia, as it fields increased scrutiny in other markets. However, the country’s government seems to have pulled the rug out from under TikTok’s feet. According to the government, the ban on social media e-commerce transactions is meant to protect offline marketplaces and merchants from the predatory pricing models on social media platforms that often outprice and threaten small…

MondayOct 02, 2023 11:42 am

Novel Type of Immunotherapy Exhibits Efficacy Against Brain Tumors in Mouse Models

A multi-institutional team of researchers has developed a novel type of cellular immunotherapy that has proven its therapeutic effectiveness in mouse models. Comprised of a researcher from the German Cancer Research Center and a University Medical Center Mannheim physician, the team used NLGN4X-specific T cells to successfully kill brain tumor cells from mice. NLGN4X (Neuroligin4X) is a protein that is involved in protein formation, and it occurs in large amounts in glioblastoma tumor cells even though they are barely present in healthy brain tissue. Glioblastoma is a type of brain cancer that originates in the nerve cell astrocytes within the…

MondayOct 02, 2023 9:00 am

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Finalizes Rebrand to Reflect New Strategic Direction, Diversification

Scinai Immunotherapeutics, a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, recently finalized a major rebrand, changing its corporate name from BiondVax Pharmaceuticals The rebrand is part of a series of steps to better reflect the company’s new direction and new developments aimed at new scientific breakthroughs Amir Reichman took over as CEO in March 2021 and together with the Board of Directors, began implementing a raft of changes aimed at redirecting the company’s focus and diversifying corporate risks Scinai is developing a pipeline of novel NanoAbs, with its development pipeline including NanoAbs for the treatment of…

FridaySep 29, 2023 2:50 pm

CDC Avails $262M to New Network Aimed at Responding to Future Disease Outbreaks

The Centers for Disease Control (CDC) will provide $262 million to fund the development of a new disease outbreak response network. Per the announcement, recipients will receive grants from the pool of more than $250 million to establish America’s first-ever response network in anticipation of future disease outbreaks. The grants will fund the development and implementation of new tools meant to detect and mitigate public health emergencies such as pandemics and disease outbreaks in the future. According to a statement from the CDC, it will distribute funds for the development of the Outbreak Analytics and Disease Modeling Network (OADMN) to…

FridaySep 29, 2023 11:15 am

PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video: Progress Report on ASD and Hope for the Future

Autism Spectrum Disorder (“ASD”) has seen a staggering fourfold increase in the United States over the past two decades PaxMedica proudly stands as the sole publicly traded U.S. company singularly dedicated to addressing the challenges posed by Autism Our pioneering lead product, PAX-101, has shown significant promise in alleviating core Autism symptoms during early trials In 2024, we're poised to submit a New Drug Application (“NDA”) for PAX-101 to treat Human African Trypanosomiasis (“HAT”), a rare disease also known as African Sleeping Sickness, as part of the Neglected Rare Tropical Disease Program With NDA approval, we anticipate the potential to…

FridaySep 29, 2023 9:00 am

Unveiling the Neuroprotective Power of CNMAu8 A Promising Breakthrough in Neurodegenerative Disease Treatment

by Elaine Mendonça On September 28, 2023, Clene Inc. (NASDAQ: CLNN) made an exciting announcement regarding their groundbreaking research on the investigational drug CNM-Au8. In a scientific paper published in the esteemed journal Small, Clene Inc. revealed the catalytic mechanism of action behind the therapeutic properties of CNM-Au8. The study showcased the remarkable neuroprotective abilities of CNM-Au8, attributing its success to its unique catalytic activity. When exposed to toxins that typically lead to neuronal death, CNM-Au8 treatment exhibited a remarkable ability to promote cell survival and preserve the intricate network of neurites. To truly understand the underlying mechanisms responsible for CNM-Au8’s neuroprotective function,…